Treatment Regimen for Parkinson's Disease

Initial Treatment Approach

The American Academy of Neurology recommends levodopa as the most effective drug for treating Parkinson's disease, with strategies to maximize its effectiveness including proper timing of medication and protein redistribution for patients experiencing motor fluctuations 1, 2

Patients should take levodopa medications at least 30 minutes before meals to avoid interactions with dietary proteins, with a strength of evidence level of high 1, 2
A protein-redistribution dietary regimen can maximize levodopa absorption and efficacy, with a recommended daily protein intake of 0.8-1.0 g/kg of body weight 1, 2
Protein redistribution should include low-protein breakfast and lunch with normal protein intake only at dinner, which improves motor function and increases "ON" state duration, with a moderate level of evidence 2
Patients on protein redistribution diets should be monitored for potential complications including weight loss, micronutrient deficits, hunger before dinner, and dyskinesias, with a high level of evidence 2

For patients with troublesome dyskinesias, reducing levodopa doses may be considered, with a moderate level of evidence 2
Deep brain stimulation (DBS) can be considered for advanced motor fluctuations resistant to oral medication adjustments, with a high level of evidence 3

When considering DBS for advanced PD, either subthalamic nucleus (STN) or globus pallidus internus (GPi) targets can be selected for treating motor symptoms, with a high level of evidence 3
STN DBS should be preferred when medication reduction is a primary goal, with a moderate level of evidence 3
If there are significant concerns about cognitive decline, GPi DBS may be preferable, with a moderate level of evidence 3
If there is significant concern about depression risk, GPi stimulation should be considered over STN, with a moderate level of evidence 3

Medical nutrition therapy should be provided to improve well-being and quality of life, tailored to individual requirements, with a high level of evidence 4
For patients with dysphagia, rehabilitation treatment should be advised after multidimensional assessment of swallowing function, with a moderate level of evidence 5
Patients on levodopa should be monitored for homocysteine levels and vitamin B status, as levodopa can cause hyperhomocysteinemia, with a high level of evidence 5
Monitor for side effects of PD medications that might influence nutritional status, including nausea, vomiting, abdominal pain, dyspepsia, constipation, weight decrease, dry mouth, and anorexia, with a high level of evidence 6

Strict low-protein diets are not supported by evidence and should be avoided, with a high level of evidence 2
Gluten-free or plant-food-based diets lack evidence for managing motor fluctuations in PD, with a moderate level of evidence 2
For tube-fed patients on oral levodopa, interrupt enteral nutrition for at least 1 hour before and 30-40 minutes after medication administration, with a high level of evidence 2
Increasing doses of levodopa over time are associated with higher risk for malnutrition, with a high level of evidence 6